Skip to content

The WORLD (Weight Optimization: Revamping Lifestyles Using the Dietary Guidelines) Study - Developing, Implementing, and Testing an Education Program

Development, Implementation, & Testing and Education Program to Teach Weight Loss Using the 2005 Dietary Guidelines to Pre-Menopausal Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00847574
Acronym
WORLD
Enrollment
101
Registered
2009-02-19
Start date
2006-03-31
Completion date
2010-12-31
Last updated
2023-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Obesity

Keywords

Weight loss, Weight maintenance, Weight management, Cardiovascular disease risk, Dietary Guidelines, Diet and exercise, Prevention

Brief summary

The WORLD study is a single-center, year-long randomized controlled trial in free-living women. Participants were randomly assigned to follow either a lower-fat (LF) diet or a moderate-fat (MF) diet for weight management in a parallel-arm design. The two phases of the study were a weight-loss phase (phase 1) and a weight-maintenance phase (phase 2) (Figure 1). During phase 1, months 1 through 4, participants consumed a hypo-caloric diet consistent with the 2005 Dietary Guidelines in the free-living environment. During phase 2, months 5 through 12, participants shifted into weight maintenance. It was hypothesized that a weight-loss intervention at the extremes of dietary fat recommendations of the 2005 Dietary Guidelines would be equally effective for weight loss while achieving comparable nutrient adequacy. Also, Overall, the lower-fat and moderate-fat diets would both be nutritionally adequate, based on the Healthy Eating Index.

Interventions

BEHAVIORALModerate-fat

35% of calories from fat

BEHAVIORALLower-fat

20% of calories from fat

Sponsors

United States Department of Agriculture (USDA)
CollaboratorFED
Penn State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 21-50 years * BMI: 25-39.9 kg/m2 * LDL-C: 100-189.9 mg/dL

Exclusion criteria

* Triglycerides \> 350 mg/dL * History of myocardial infarction, stroke, diabetes mellitus, liver disease, kidney disease, and thyroid disease * High alcohol consumption (\<14 drinks/week) * Use of medication or supplements for lowering blood lipid levels (i.e., statin, fibrates, psyllium, fish oil capsules, soy lecithin, phytoestrogens) * Lactating, pregnant, or wanting to become pregnant during the study * Weight loss or gain ≥ 10% body weight in the previous 6 months * Eating Attitudes Test-26 score \> 20 * Beck Depression Inventory-II score ≥ 29 * Gormally Cognitive Factors Related to Binge Eating Scale score \> 30 * Physical Activity Readiness Questionnaire score \> 2

Design outcomes

Primary

MeasureTime frame
Body weightBaseline, month 4, month 8, month 12

Secondary

MeasureTime frame
GlucoseBaseline, month 4, month 8, month 12
InsulinBaseline, month 4, month 8, month 12
C-reactive proteinBaseline, month 4, month 8, month 12
Lipid ProfileBaseline, month 4, month 8, month 12
Body compositionBaseline, month 4, month 12
Fitness via VO2maxBaseline, month 4, month 12
Cognitive-behavioral measuresBaseline, month 4, month 8, month 12
Dietary intakeBaseline, month 4, month 12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026